Treatment of Schizoaffective Disorder Using Mifepristone
Trial ID or NCT#
Status
Purpose
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Official Title
Treatment of Schizoaffective Disorder Using Mifepristone
Eligibility Criteria
- The subjects will be 30 inpatients or outpatients with schizoaffective disorder.
- Subjects must be between the ages of eighteen and seventy-five without major medical problems.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Jessica Hawkins
6507238323
View on ClinicalTrials.gov